A new option for adults who have experienced stroke will now be available to further reduce future risk.
News|Articles|April 9, 2008
WellPoint NextRx pilots over-the-counter medication program with Blue Cross & Blue Shield of Rhode Island
WellPoint Next Rx pilots OTC generic program with Blue Cross & Blue Shield of Rhode Island to help offset out-of-pocket costs for members.
Advertisement
Advertisement
Related to this article
Findings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.
Gilead’s current lenacapavir patent is what makes Dr Reddy’s Laboratories’ formulation tentative.
The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
The Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.
Through the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.
The medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.
In part 3, Rebold explores improving the ART formulary protocol through introducing pharmacist-led transition-of-care services.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Adds NAION Eye Risk Warning to All GLP-1 Labels
2
The Pharmacy Model Creating New Billing Pathways, Improved Recognition
3
Doxycycline Use Associated with Higher Risk of Pregnancy Loss
4
New Report Finds Pharmacies Key in Long-Term GLP-1 Success
5